Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Post by august202013on Feb 10, 2021 12:30pm
296 Views
Post# 32526245

ONLY SELECTED FEW USA FDA'S OFFICIALS KNOWS

ONLY SELECTED FEW USA FDA'S OFFICIALS KNOWSAs for MIR's dynamic DUO they have to immediately NOTIFY TSX to officially HALT MIR from trading on THAT day for ANY announcement. Based on the last 2 EUA that was updated at this FORUM chances are MIR most likely be next hopefully and also as previously made know to US at this FORUM USA FDA normally make their announcement on THURSDAY for some obvious reasons best known to them BUT most likely because come THURSDAY when HALTED and trading resumes on Friday things could be smoothly conducted. Come the weekend announcement get digested for reopening on MONDAY. So that is the story. Good luck otherwise could be the next few weeks. But ultimately USA FDA Should issue MIR THEIR 2nd EUA for their COVID19 test kit with PLUS. As still believe it was USA FDA fault that MIR has to resubmit for thIs 2nd EUA. The mockery otherwise will be on USA FDA as they should not be CALLED Emergency As there is some element of URGENCY. Quite sure HAS been more than 3 weeks since MIR reSUBMISSION of the COVID19 PLUS. Work load could be a factor in a 3rd world countries NOT in case of USA FDA where budget is never a factor thanks to the 1944 Bretton Wood Accord.
<< Previous
Bullboard Posts
Next >>